Filter News
Area of Research
News Type
News Topics
- (-) Artificial Intelligence (1)
- (-) Fusion (1)
- (-) Grid (1)
- (-) Isotopes (2)
- (-) Materials Science (1)
- (-) Space Exploration (2)
- (-) Transportation (1)
- Advanced Reactors (4)
- Big Data (1)
- Biomedical (1)
- Computer Science (3)
- Cybersecurity (1)
- Machine Learning (1)
- Molten Salt (3)
- Neutron Science (1)
- Nuclear Energy (14)
- Security (2)
Media Contacts
As scientists study approaches to best sustain a fusion reactor, a team led by Oak Ridge National Laboratory investigated injecting shattered argon pellets into a super-hot plasma, when needed, to protect the reactor’s interior wall from high-energy runaway electrons.
If humankind reaches Mars this century, an Oak Ridge National Laboratory-developed experiment testing advanced materials for spacecraft may play a key role.
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
Gleaning valuable data from social platforms such as Twitter—particularly to map out critical location information during emergencies— has become more effective and efficient thanks to Oak Ridge National Laboratory.
By automating the production of neptunium oxide-aluminum pellets, Oak Ridge National Laboratory scientists have eliminated a key bottleneck when producing plutonium-238 used by NASA to fuel deep space exploration.
Thought leaders from across the maritime community came together at Oak Ridge National Laboratory to explore the emerging new energy landscape for the maritime transportation system during the Ninth Annual Maritime Risk Symposium.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.